Phase II study of fludarabine phosphate (NSC-312887) in patients with advanced endometrial cancer: A southwest oncology group study

D. D. Von Hoff, S. Green, D. S. Alberts, D. L. Stock-Novack, E. A. Surwit, T. P. Miller, R. L. Stephens

Research output: Contribution to journal › Article › peer-review

8 Scopus citations

Fingerprint

Dive into the research topics of 'Phase II study of fludarabine phosphate (NSC-312887) in patients with advanced endometrial cancer: A southwest oncology group study'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science

Keyphrases

Medicine and Dentistry